Related Experiment Video
Updated: Jul 16, 2026

Dioscin Mediated IgA Nephropathy Alleviation by Inhibiting B Cell Activation In Vivo and Decreasing Galactose-Deficient IgA1 Production In Vitro
Published on: October 13, 2023
[Secondary IgA-nephropathy in gastroenterological diseases]
Nóra Szigeti1, Tibor Kovács, Péter Degrell
1Pécsi Tudományegyetem, Altalános Orvostudományi Kar, II. Belgyógyászati Klinika és Nefrológiai Centrum, Pécs. szigetinora@freemail.hu
This study focuses on secondary IgA-nephropathy linked to gastrointestinal and liver diseases. Further research is needed to understand the frequency of these connections.
Area of Science:
- Nephrology
- Gastroenterology
- Immunology
Context:
- IgA-nephropathy (IgAN) is a leading cause of chronic kidney disease globally.
- Secondary IgAN, associated with other organ diseases, is increasingly recognized.
- This review specifically examines secondary IgAN related to gastroenterological conditions, including liver diseases.
Purpose:
- To highlight the association between IgA-nephropathy and gastrointestinal diseases.
- To emphasize the importance of investigating liver diseases, celiac disease, Crohn's disease, and ulcerative colitis in IgAN patients.
- To advocate for a national study on the prevalence of IgAN in patients with these gastrointestinal conditions.
Summary:
- The study reviews secondary IgA-nephropathy, focusing on its links with gastroenterology and liver conditions.
- It stresses the need to examine co-occurring gastrointestinal diseases in IgAN patients.
- The authors propose a nationwide clinical analysis to determine the frequency of IgAN in patients with specific GI diseases.
Impact:
- Increases awareness of the gastrointestinal origins of secondary IgA-nephropathy.
- Promotes a more integrated diagnostic approach for IgAN patients.
- Lays the groundwork for future epidemiological studies and improved patient management strategies.
Related Concept Videos
Nephrotic Syndrome I : Introduction
Gastritis-II: Pathophysiology
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
Nephrotic Syndrome II : Assessment and Medical Management
Gastritis-I: Introduction and Types
Acute gastritis presents as a sudden inflammation triggered by various stressors to the stomach lining, such as exposure to corrosive agents, local irritants like aspirin and other NSAIDs, alcohol consumption, radiation therapy, physical trauma, severe burns, sepsis,...
Gastritis II: Pathophysiology
Gastritis III: Clinical Manifestations and Management
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...

